Top Story
Malaria vaccine proves promising in Mali trial
An experimental malaria vaccine originally developed by GlaxoSmithKline and the U.S. Army has produced dramatic results in an early-stage trial in Mali. Researchers recruited 100 children who are between 1 and 6 years old for the trial and found that the jab provided the same kind of immunity as lifelong exposure to the disease. The children's immune response jumped 100-fold. Report
Latest News
Lancet retracts controversial autism study
Twelve years ago, Dr. Andrew Wakefield published a study in the Lancet that linked autism with childhood vaccines, triggering an explosive controversy that continues to influence public opinion about... Read more...
Malaria vaccine proves promising in Mali trial
An experimental malaria vaccine originally developed by GlaxoSmithKline and the U.S. Army has produced dramatic results in an early-stage trial in Mali. Researchers recruited 100 children who are... Read more...
PATH pays FDA for vax development
The nonprofit group PATH is seeking help from the FDA to develop a vaccine against diseases caused by the Streptococcus pneumoniae bacteria, which kills almost 1 million children each year. And the... Read more...
Pharma turns to small developers for vax tech
Paul Bogorad at Putnam Associates is bullish about the vaccine business. Reviewing the now familiar story line about Big Pharma's embrace of vaccines after years of neglect, Mass High Tech relates... Read more...
Poor nations still waiting for H1N1 vax
When affluent nations scrambled to get in the front of the line last year for the first shipments of swine flu vaccine, the World Health Organization had been hoping to snare a significant portion of... Read more...
Rotavirus vax campaign would save millions of lives
Each year, more than half a million children around the world die from rotavirus infection--more than half of them in sub-Saharan Africa. But now two new studies conclude that a widespread... Read more...
Finalists ponder fate of $88M HIV facility
The four finalists for an $88 million project to build a new facility in Canada to produce an HIV vaccine say the government has left them in the dark about the reasons why no one has been selected... Read more...
Study: Immunotherapy helped prostate cancer patients live longer
Metastatic prostate cancer patients who received a vaccine of poxviruses engineered to spur an immune system attack on prostate tumor cells lived more than eight months longer those receiving a... Read more...
Latest Comments
News Timeline
Breaking swine flu news
Want more information on the ongoing swine flu outbreak? Get breaking news and more details here. TimelineFrom The Network
Also Noted
H1N1
> Sales of the H1N1 vaccine helped lift GlaxoSmithKline's profit to $2.6 billion in the fourth quarter. Report
> The Czech Republic says it is in talks with GlaxoSmithKline to see if it can cancel at least part of its scheduled shipment of H1N1 vaccine. Story
> A total of 112 people have been killed by swine flu in Hungary. Story
Vaccine Research
> Bill Gates has pledged to give $10 billion of his fortune to research, develop and deliver new vaccines that can prevent diarrhea and pneumonia. "We must make this the decade of vaccines," Gates said during the World Economic Forum in Davos, Switzerland. Report
Read more >>Press Releases
- Sistemic Closes $1m Series A Funding Round
- Lux Biosciences Files for LUVENIQ Approval in US and Europe for Noninfectious Uveitis
- Virus-Like Particle Vaccine Protects Monkeys from Chikungunya Virus
- GSK launches new specialist unit to research and develop medicines for rare diseases
- Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
- Leading Chinese Pharmaceuticals Retailer and Distributor Lerentang Group Selects Manhattan Associates
